PAYMENT OF TECHNOLOGY ACCESS FEES. ▇▇▇▇▇▇ Corp. II shall pay Five Hundred Thousand Dollars ($500,000) on or before the forty-fifth (45th) day following the end of each calendar quarter, fifty percent (50%) to DURA, twenty percent (20%) to DDSI and thirty percent (30%) to ▇▇▇▇▇▇ Corp. Within sixty (60) days following the end of each calendar year, ▇▇▇▇▇▇ Corp. II shall provide to DURA, DDSI and ▇▇▇▇▇▇ Corp. a formal accounting of the Net Sales of each ▇▇▇▇▇▇ Product in such calendar year (the "Accounting"), and shall calculate the aggregate sum with respect to sales of all ▇▇▇▇▇▇ Products which would be due if ▇▇▇▇▇▇ Corp. II were to pay DURA five percent (5%) of the Net Sales in a calendar year for each ▇▇▇▇▇▇ Product (the "Net Sales Amount"). In the event that the Net Sales Amount is less than Two Million Dollars ($2,000,000), no additional payments shall be due and payable from ▇▇▇▇▇▇ Corp. II with respect to access to the Core Technology. In the event that the Net Sales Amount is greater than Two Million Dollars ($2,000,000), ▇▇▇▇▇▇ Corp. II shall promptly pay, but in no event later than five (5) business days following delivery of the Accounting to DURA, DDSI and ▇▇▇▇▇▇ Corp., the difference between the Net Sales Amount and Two Million Dollars ($2,000,000) with respect to access to the Core Technology, fifty percent (50%) to DURA, twenty percent (20%) to DDSI and thirty percent (30%) to ▇▇▇▇▇▇ Corp.
Appears in 2 contracts
Sources: Technology License Agreement (Dura Pharmaceuticals Inc/Ca), Technology License Agreement (Spiros Development Corp Ii Inc)
PAYMENT OF TECHNOLOGY ACCESS FEES. ▇▇▇▇▇▇ Corp. II shall pay Five Hundred Thousand Dollars ($500,000) on or before the forty-fifth (45th) day following the end of each calendar quarter, fifty ______ percent (50___%) to DURA, twenty ______ percent (20___%) to DDSI and thirty ______ percent (30___%) to ▇▇▇▇▇▇ Corp. Within sixty (60) days following the end of each calendar year, ▇▇▇▇▇▇ Corp. II shall provide to DURA, DDSI and ▇▇▇▇▇▇ Corp. a formal accounting of the Net Sales of each ▇▇▇▇▇▇ Product in such calendar year (the "Accounting"), and shall calculate the aggregate sum with respect to sales of all ▇▇▇▇▇▇ Products which would be due if ▇▇▇▇▇▇ Corp. II were to pay DURA five percent (5%) of the Net Sales in a calendar year for each ▇▇▇▇▇▇ Product (the "Net Sales Amount"). In the event that the Net Sales Amount is less than Two Million Dollars ($2,000,000), no additional payments shall be due and payable from ▇▇▇▇▇▇ Corp. II with respect to access to the Core Technology. In the event that the Net Sales Amount is greater than Two Million Dollars ($2,000,000), ▇▇▇▇▇▇ Corp. II shall promptly pay, but in no event later than five (5) business days following delivery of the Accounting to DURA, DDSI and ▇▇▇▇▇▇ Corp., the difference between the Net Sales Amount and Two Million Dollars ($2,000,000) with respect to access to the Core Technology, fifty ______ percent (50___%) to DURA, twenty ______ percent (20___%) to DDSI and thirty ______ percent (30___%) to ▇▇▇▇▇▇ Corp.
Appears in 1 contract
Sources: Technology License Agreement (Dura Pharmaceuticals Inc/Ca)